Original filing text · Part II

Item 1 — Legal Proceedings

Atea Pharmaceuticals, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

We are not subject to any material legal proceedings.